FORGOTTEN HISTORY: 31 | History Defined

What's Going On With Moderna Shares?

Shares of vaccine companies, including Moderna Inc (NASDAQ: MRNA), are trading higher amid COVID-19 concerns due to rising cases in China.

Benzinga · Apr 25, 2022

This Is What Whales Are Betting On Moderna

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Apr 25, 2022

US can manage BA.2 variant ‘without disruption’, top Covid adviser predicts

Ashish Jha says spreading variant unlikely to have much effect on the nation’s pandemic recovery

The Guardian - US · Apr 24, 2022

If You Invested $1,000 In Moderna Stock At Its Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga · Apr 20, 2022

Parents of kids under 5 still waiting for COVID shots

The demise of the federal transportation mask mandate was particularly jarring for many parents of children under five anxiously waiting for word on when COVID shots will become available to their kids.

Axios · Apr 20, 2022

Moderna says redesigned COVID-19 vaccine booster may work better against variants

Moderna’s updated COVID-19 booster shot shows even more efficiency against variants, the pharmaceutical company announced Tuesday, citing preliminary results from a trial.

Tribune News Service · Apr 20, 2022

Computer modelling to aid search for HIV vaccine

The search continues at a brisk pace thanks to rapid developments in generating more potent computing power.

360info · Apr 20, 2022

Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab

Moderna Inc (NASDAQ:MRNA) said a COVID-19 booster designed to target the Beta variant and the original coronavirus generated a better immune response against several virus variants, including Omicron. Moderna said the results were a good sign for the company's plans for future shots targeting two COVID-19 variants. The company said the bivalent…

Benzinga · Apr 19, 2022

Moderna announces step toward updating COVID shots for fall

Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant

The Independent UK · Apr 19, 2022

J&J suspends COVID-19 vaccine sales forecast

Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as $3.5 billion this year

The Independent UK · Apr 19, 2022